Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid-positive individuals

INTRODUCTION: Neurofilament light chain (NfL) is a promising blood biomarker to detect neurodegeneration in Alzheimer's disease (AD) and other brain disorders. However, there are limited reports of how longitudinal NfL relates to imaging biomarkers. We herein investigated the relationship betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Benedet, Andréa L., Ashton, Nicholas J., Pascoal, Tharick A., Leuzy, Antoine, Mathotaarachchi, Sulantha, Kang, Min S., Therriault, Joseph, Savard, Melissa, Chamoun, Mira, Schöll, Michael, Zimmer, Eduardo R., Gauthier, Serge, Labbe, Aurélie, Zetterberg, Henrik, Blennow, Kaj, Neto, Pedro R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Special Section: Blood-Based Biomarkers for Alzheimer's Disease & Related Dementias. (Editor: Henrik Zetterberg)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816316/
https://www.ncbi.nlm.nih.gov/pubmed/31673598
http://dx.doi.org/10.1016/j.dadm.2019.08.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816316/
https://www.ncbi.nlm.nih.gov/pubmed/31673598
http://dx.doi.org/10.1016/j.dadm.2019.08.002

Ejemplares similares